Genicular artery embolization is a new, minimally invasive treatment for chronic knee pain from osteoarthritis, the most common type of arthritis of the knees, usually due to age-related changes, weight-bearing, and overuse.
Genicular artery embolization (GAE) is a new, minimally invasive treatment for chronic knee pain caused by osteoarthritis. Osteoarthritis is the most common type of arthritis affecting the knees, typically due to:
GAE works by blocking a small percentage of blood flow to the knee’s capsular arteries (synovium) to reduce inflammation.
This procedure is an alternative to knee replacement surgery for patients with moderate osteoarthritis who have not responded to conservative treatments.
✔
Pain relief usually begins within a few days.
✔
The full effects typically occur around 2 weeks.
Patients typically go home the same day shortly after the procedure.
Patients can walk on their own immediately after the procedure
Gradual return to activity is expected over the next few days.
Most patients experience greater than 50% reduction in pain scores as early as 3 days after the procedure.
Pain relief can last at least 1 year, and for many, over 2 years or longer.
✔ A systematic review of 10 different studies showed:
Key Benefit: Other research supports GAE’s ability to reduce inflammation and improve knee function in mild to moderate osteoarthritis patients.
GAE is considered a low-risk outpatient procedure, but like other vascular procedures, some risks exist.
✔
Skin discoloration around the knee (occurs in ~12% of patients) but typically
clears within a few days.
✔
Mild soreness or swelling at the catheter site, usually resolving within a few days.
✔ Bleeding, blood clots, or vascular injury (~0.6%)
✔ Unintended Particle Migration: treatment involves the injection of small particles into the blood vessels of the knee. These vessels often have small branches that pass to other tissues and vessels (collaterals),
✔ Possible minor rash, blisters, or small ulcers (~0.3%)
✔ Larger unintended embolization (exceedingly rare)
✔ Sedation risks: The procedure is performed under mild sedation rather than general anesthesia
If you have chronic knee pain lasting for more than 6 months and have tried conservative measures for pain control such as medications, joint injections, physical therapy, or other measures without satisfactory results, you are likely a candidate.
To qualify, you must have significant knee pain that is on average 5 or higher on a scale of 1 to 10. It must also affect your normal activities of daily living, such as climbing stairs, walking, standing, getting dressed, getting up from a chair, or other similar activities.
It also requires an imaging diagnosis on x-ray or MRI of osteoarthritis that correlate with the pain and show evidence of mild to moderate disease.
Most patients are also 45 years or older. In some cases of chronic, persistent pain after knee replacement surgery, you may qualify for treatment if other conservative measures have failed, and your surgeon does not recommend joint replacement or revision.
Patients may not qualify if they have advanced, severe osteoarthritis, where joint replacement is recommended.
It is also not recommended if you have a joint infection, any knee surgery in the past 6 months, inflammatory arthritis (i.e. Rheumatoid Arthritis), and in severe cases of vascular disease (peripheral arterial disease), severe cardiac disease, or other medical conditions that preclude performing the procedure safely.
Most standard, traditional insurances including Medicare cover the procedure if you meet medical requirements and necessity. We obtain pre-authorization from your insurance prior to performing the procedure. If you are out of network or do not have insurance, we can offer cash pay options, which would be discussed during the consultation.
The short answer is yes. The first treatment was performed in 2015 and has had numerous research
studies showing its effectiveness. However, it is still relatively new, and more research is being
performed and ongoing. Below are some studies if you are curious about the most recent scientific
research supporting this treatment:
1. Taslakian B, Miller L, Mabud T, et al. Genicular artery embolization for treatment of knee osteoarthritis
pain: Systematic review and meta-analysis. Osteoarthr Cartil Open. 2023 Feb 6;5(2):100342.
2. Tyagi R, Ahmed SS, Koethe Y, et al. Genicular artery embolization for primary knee osteoarthritis.
Semin Intervent Radiol. 2022 Jun 30;39(2):125-129.
3. Padia SA, Genshaft S, Blumstein G, et al. Genicular artery embolization for treatment of symptomatic
knee osteoarthritis. JB JS Open Access. 2021 Oct 21;6(4): e21.0085
4. Little MW, Gibson M, Briggs J, et al. Genicular artery embolization in patients with osteoarthritis of the
knee (GENESIS) using permanent microspheres: Interim Analysis. Cardiovasc Intervent Radiol. 2021
Jun;44(6):931-940.
5. Bagla S, Piechowiak 5. Bagla S, Piechowiak R, Hartman T, Orlando J, Del Gaizo D, Isaacson A.
Genicular artery embolization for the treatment of knee pain secondary to osteoarthritis. J Vasc Interv
Radiol. 2020;31(7):1096–1102
6. Okuno Y, Korchi AM, Shinjo T, Kato S, Kaneko T. Midterm clinical outcomes and MR imaging changes
after transcatheter arterial embolization as a treatment for mild to moderate radiographic knee
osteoarthritis resistant to conservative treatment. J Vasc Interv Radiol. 2017;28(7):995–1002.
7. Torkian P, Golzarian J, Chalian M, et al. Osteoarthritis-related knee pain treated with genicular artery
embolization: a systematic review and meta-analysis. Orthop J Sports Med.
2021;9(7):23259671211021356.
All Rights Reserved | Evolve Medical